Marimed (MRMD) Receivables - Other (2016 - 2024)
Marimed (MRMD) has disclosed Receivables - Other for 12 consecutive years, with $302000.0 as the latest value for Q3 2024.
- On a quarterly basis, Receivables - Other rose 247.13% to $302000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $302000.0, a 247.13% increase, with the full-year FY2023 number at $105000.0, up 262.07% from a year prior.
- Receivables - Other was $302000.0 for Q3 2024 at Marimed, up from $233000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $29.0 million in Q4 2020 to a low of $9937.0 in Q3 2020.
- A 5-year average of $2.9 million and a median of $143000.0 in 2023 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: tumbled 99.96% in 2020, then skyrocketed 565.71% in 2024.
- Marimed's Receivables - Other stood at $29.0 million in 2020, then tumbled by 82.76% to $5.0 million in 2021, then crashed by 99.42% to $29000.0 in 2022, then soared by 262.07% to $105000.0 in 2023, then surged by 187.62% to $302000.0 in 2024.
- Per Business Quant, the three most recent readings for MRMD's Receivables - Other are $302000.0 (Q3 2024), $233000.0 (Q2 2024), and $181000.0 (Q1 2024).